The board of directors of Regenesis Biomedical, a privately held medical technology company focused on tissue regeneration, has unanimously elected Scott Brooks as the next chief executive officer and member of the board of directors, succeeding Virginia Rybski. Brooks will assume his new role immediately.
Brooks has served as Regenesis' chief operating officer since January 2012 and will become the fourth CEO in Regenesis' history. His career spans senior management positions in BSN medical, KCI, Hill-Rom Company and Kimberly-Clark Healthcare, across sales and marketing, business development, national accounts and operations.
Scott is also a former executive committee member of the Federation of American Hospital Systems and was on the board at the American College of Phlebology Foundation.